I would wait until the end of September to obtain an accurate count; the monotherapy trial was/is a disaster.
Data was presented at the AES meeting via poster format so nothing is new. I am not a fortune teller regarding the FDA or sales force decisions. If approved the data may look different than one might expect so just sharing so people are mentally prepared.